Interatrial Shunt Conduit With Discrete Frames for Thrombosis Resistance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing treatments for heart failure, such as heart diseases and hypertension, lack adaptable methods and devices that effectively manage blood pressure between heart chambers and reduce thrombosis risk.

Innovation Solution

An implantable medical device with discrete frame components and a conduit portion, featuring a membrane unsupported by the frame components, allows for customizable deployment and fluid flow management, reducing thrombosis risk and enhancing therapeutic efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If a continuous frame structure is used to support the conduit, then structural strength is improved, but thrombosis risk increases due to frame components within the conduit lumen

Engineering Contradiction:
Improvestructural strengthVSAvoidthrombosis risk
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The frame is divided into discrete separate components (first frame component and second frame component) positioned at opposite ends of the conduit portion, with no frame components within the conduit lumen. This segmentation maintains structural strength while eliminating thrombosis risk by removing continuous frame support from the fluid flow path.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Frame components are extracted from the conduit portion entirely, with the conduit being free of frame components within its length. The frame components are positioned only at the ends, connecting to the membrane but not extending into the conduit lumen, thereby removing the source of thrombosis risk while preserving structural integrity through end-support mechanisms.

Inventive Principle:
Principle #2Taking out (Extraction)

2Stability of the object's composition

If the conduit portion is fully supported by frame components, then structural stability is improved, but adaptability to different anatomies is reduced

Engineering Contradiction:
Improvestructural stabilityVSAvoidanatomy conformance
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The frame is segmented into discrete components at the ends of the conduit, allowing the membrane to conform to varying anatomical shapes while the end frame components provide stable anchoring points. This segmentation enables adaptation to different anatomies without compromising structural stability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The membrane is made radially unsupported and flexible, allowing it to dynamically adapt to different anatomical configurations while the discrete frame components at the ends provide stable anchoring. This dynamic membrane can conform to various shapes while maintaining structural integrity through its boundary conditions.

Inventive Principle:
Principle #15Dynamics

3Ease of operation

If frame components are placed within the conduit portion, then deployment control is improved, but endothelization is inhibited due to frame presence

Engineering Contradiction:
Improvedeployment controlVSAvoidendothelization
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The frame is segmented into discrete components positioned only at the ends of the conduit, allowing deployment control to be exercised through the frame components and delivery system while the conduit portion remains free of frame components. This enables full endothelization of the conduit surface without compromising deployment control.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Frame components are extracted from the conduit portion, removing obstacles to endothelization. The conduit is made free of frame components within its length, allowing complete endothelial cell coverage while deployment control is maintained through the end frame components and delivery catheter system.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS12514707B2Medical devices for shunts, occluders, fenestrations and related systems and methods
Publication Date: 2026.01.06 WL GORE & ASSOC INC
  • US12514707B2 patent drawing
  • US12514707B2 patent drawing
  • US12514707B2 patent drawing

AI summary

An implantable medical device comprising a first frame component. The first frame component including a first set of elongate elements configured to conform to an anatomy of a patient. The implantable medical device also comprising a second frame component including a second set of elongate elements configured to conform to an anatomy of a patient. The first frame component and the second frame component being discrete and separate from one another. The implantable medical device also comprising a conduit portion arranged between the first frame component and the second frame component. The conduit portion including a membrane connecting the first frame component and the second frame component.